ArticlePlant biotechnology journal2026
Nicotiana benthamiana as a Source of Cowpea Mosaic Virus-Derived Particles That Specifically Package Designer RNAs.
Article in Plant biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The coupling of replication and encapsidation in the bipartite plant virus, cowpea mosaic virus (CPMV), has been used to specifically incorporate designer RNA molecules into viral particles via transient expression in Nicotiana benthamiana. This is achieved by placing the desired RNA sequence between the 5' and 3' UTRs of CPMV RNA-2 so that the cargo RNA can be recognised by the RNA-1-encoded replicase. Replication and encapsidation of cargo RNA are achieved by co-infiltrating with CPMV RNA-1 to provide replication functions and a non-replicating construct that encodes the precursor of the viral coat proteins, VP60. Encapsidation within CPMV particles stabilises the RNA such that it can be stored for prolonged periods at +4°C. Investigation of the length and sequence of the RNA that can be efficiently incorporated showed that a wide range of different RNA molecules are tolerated, provided that the length does not significantly exceed that of RNA-1 (6.0 kb). In contrast to previously published conclusions, we show here that a self-replicating version of RNA-1 is not required for the replication and packaging of cargo RNA constructs. Use of a non-replicating version of RNA-1 not only eliminates the packaging of RNA-1 but also increases the yield of particles containing the desired cargo RNA. Such particles have the potential to be used as delivery systems for bespoke RNAs to target cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.